Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Norrie Disease (Pseudoglioma) (NDP) Peptide

NDP Reactivité: Mammifères Hôte: Synthetic BP, IHC, WB
N° du produit ABIN937500
  • Antigène Tous les produits Norrie Disease (Pseudoglioma) (NDP)
    Norrie Disease (Pseudoglioma) (NDP)
    Type de proteíne
    Synthetic
    Origine
    Mammifères
    Source
    • 1
    Synthetic
    Application
    Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
    Séquence
    DPRRCMRHHY VDSISHPLYK CSSKMVLLAR CEGHCSQASR SEPLVSFSTV
    Attributs du produit
    A synthetic peptide for use as a blocking control in assays to test for specificity of NDP antibody,
    Alternative Names: NDP control peptide, NDP antibody Blocking Peptide, Anti-NDP Blocking Peptide, Norrie Disease Blocking Peptide, Pseudoglioma Blocking Peptide, EVR2 Blocking Peptide, FEVR Blocking Peptide, ND Blocking Peptide
    Purification
    Rabbit Anti-p44/42 MAP Kinase (Ab-202) Polyclonal Antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific immunogen.
  • Indications d'application
    Optimal conditions should be determined by the investigator
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
    Buffer
    PBS
    Conseil sur la manipulation
    Avoid repeated freeze/thaw cycles.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20 °C long term.
  • Antigène
    Norrie Disease (Pseudoglioma) (NDP)
    Synonymes
    EVR2 Peptide, FEVR Peptide, ND Peptide, evr2 Peptide, fevr Peptide, xnorrin Peptide, Ndph Peptide, RGD1563968 Peptide, NDP, norrin cystine knot growth factor Peptide, Norrie disease (pseudoglioma) L homeolog Peptide, Norrie disease (pseudoglioma) (human) Peptide, NDP Peptide, ndp.L Peptide, Ndp Peptide
    Sujet
    NDP activates the canonical Wnt signaling pathway through FZD4 and LRP5 coreceptor. NDP plays a central role in retinal vascularization by acting as a ligand for FZD4 that signals via stabilizing beta-catenin (CTNNB1) and activating LEF/TCF-mediated transcriptional programs. NDP acts in concert with TSPAN12 to activate FZD4 independently of the Wnt-dependent activation of FZD4, suggesting the existence of a Wnt-independent signaling that also promote accumulation the beta-catenin (CTNNB1).
    Poids moléculaire
    15 kDa
Vous êtes ici:
Support technique